Cargando…
Management of HIV-2 resistance to antiretroviral therapy in a HIV-1/HIV-2/HBV co-infected patient
BACKGROUND: The current standard of care is to start antiretroviral therapy in all patients diagnosed with HIV-1, as for HIV-2 current DHHS guideline suggests ART for HIV-2 as soon as diagnosis is established, although this practice is not universal, for instance, in Portugal there are specific crit...
Autores principales: | Cardoso, Margarida, Vasconcelos, Joana, Baptista, Teresa, Diogo, Isabel, Gonçalves, Fátima, Mansinho, Kamal, Gomes, Perpétua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507372/ https://www.ncbi.nlm.nih.gov/pubmed/34641890 http://dx.doi.org/10.1186/s12981-021-00394-4 |
Ejemplares similares
-
Durability of first antiretroviral treatment in HIV chronically infected patients: why change and what are the outcomes?
por: Moniz, Patricia, et al.
Publicado: (2014) -
Clinical and laboratorial impact of antiretroviral therapy in a cohort of Portuguese patients chronically infected with HIV-2
por: Miranda, Ana, et al.
Publicado: (2014) -
Characteristics and outcomes of antiretroviral-treated HIV-HBV co-infected patients in Canada?
por: Rana, Urvi, et al.
Publicado: (2019) -
Evolution trends over three decades of HIV infection late diagnosis: the experience of a Portuguese cohort of 705 HIV-infected patients
por: Claudia Miranda, Ana, et al.
Publicado: (2014) -
HIV-2 Integrase Polymorphisms and Longitudinal Genotypic Analysis of HIV-2 Infected Patients Failing a Raltegravir-Containing Regimen
por: Cavaco-Silva, Joana, et al.
Publicado: (2014)